PROVECTUS BIOPHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $1.63 million for the 12-month period ending 2005-12-31, per its 10-Q filed 2014-08-07.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2014-08-07
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|
| 2005-12-31 | $1.63M 10-Q · filed 2014-08-07 |
| 2004-12-31 | $360.26K 10-Q · filed 2014-08-07 |
| 2003-12-31 | $601.00K 10-Q · filed 2014-08-07 |